Padcev الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

padcev

astellas pharma europe b.v. - enfortumab vedotin - carcinoma, transitional cell; urologic neoplasms - antineoplastiske midler - padcev as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have previously received a platinum-containing chemotherapy and a programmed death receptor 1 or programmed death ligand 1 inhibitor.

Sugammadex Amomed الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

sugammadex amomed

aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskulær blokade - alle andre terapeutiske produkter - tilbagevendelse af neuromuskulær blokade induceret af rocuronium eller vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Trabektedin "Sun" 1 mg pulver til koncentrat til infusionsvæske, opløsning الدانمرك - الدانماركية - Lægemiddelstyrelsen (Danish Medicines Agency)

trabektedin "sun" 1 mg pulver til koncentrat til infusionsvæske, opløsning

sun pharmaceutical industries europe bv - trabectedin - pulver til koncentrat til infusionsvæske, opløsning - 1 mg